Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-06-12

Clinical Trial Update: Impact of Eszopiclone on Blood Pressure in Patients With Insomnia and Hypertension (PRYSMA-HTN) [Phase 4]

View source ↗

Summary

This clinical trial update describes an ongoing Phase 4 study (PRYSMA-HTN) evaluating the effect of eszopiclone on blood pressure in adults with insomnia and hy…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Lunesta (eszopiclone)

Snippet

Sponsor: University of Sao Paulo | Conditions: Insomnia, Hypertension | Phase 4 | Status: RECRUITING